An extended proposal deadline has been issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) for a Small Business Innovation Research (SBIR) contract solicitation.
The agencies seek small businesses that possess the research and development expertise to conduct innovative research that will contribute toward meeting their program objectives.
An abbreviated list of topics of interest includes:
National Institute of Allergy and Infectious Diseases (NIAID): Integrated Multiplex Medical Diagnostics Platforms for Infectious Diseases; Aerosolized Delivery of Anti-Tubercular Drugs; Development of Long-Acting Formulations of HIV Anti-Retrovirals; Improved Formulations for Approved First and Second line anti-Tuberculosis (TB) Drugs
National Center for Immunization and Respiratory Diseases (NCIRD): Development of an Inactivated Rotavirus Vaccine for Use in Global Immunization; Thermostable Dry Measles Vaccine Formulation for Sublingual Administration
National Center for Emerging Zoonotic and Infectious Diseases (NCEZID): Development of Nanoparticle Dengue Diagnostic Tests; Development of Tests in a Standardized Kit Format for Diagnosis of Arboviral Infections in Resource-Limited, Primary Health Care Setting; Reducing Antimicrobial Resistance through Improved use of Laboratory Testing Information in Healthcare Facilities
CDC Center for Global Health (CGH): Diagnostic Needs for Neglected Tropical Diseases (NTD) Programs; Rapid Screening Tests to Prevent Congenital Infections and Ensure Blood Safety; Development of Diagnostic Tests for Strongyloidiasis and Schistosomiasis
National Center for Advancing Translational Sciences (NCATS): Assay Development for High-Throughput Screening of Chemicals of Toxicological Concern; Visualizing Knowledge about Human Health and the Pathways of Translation; Biomarker Study for Creatine Transporter Defect Disorders; Automated Instrument to Clean Microtiter Plates
National Heart, Lung and Blood Institute (NHLBI): Improving Safety and Efficacy of Red Blood Cells for Transfusion; Fluorescent Nanodiamonds for In Vitro and In Vivo Biological Imaging
National Cancer Institute (NCI): RNAi Cancer Therapeutics using Nanotechnology; Development of Human Tissue Culture Systems that Mimic the Tumor Microenvironment; Development of CTC Isolation Technologies Enabling Downstream Single Cell Molecular Analysis; Wound Healing Preparations Incorporating Nitric Oxide-Releasing Materials; Technology to Generate Anti-Peptide Capture Reagents for Affinity-Enriched Proteomic Studies; Chemically Defined Glycan Libraries for Reference Standards and Glycomics Research; Novel Imaging Agents to Expand the Clinical Toolkit; Innovative Radiation Sources for Advanced Radiotherapy Equipment
Office of Public Health Preparedness and Response (OPHPR): Improved Methods for Collection, Preservation, and Transportation of Biological Specimens
Further details are available under Solicitation Number: PHS2013-1. The proposal response deadline was recently extended to December 3, 2012.
